Open Label Prospective Study of Strategies to Combine Pre-Exposure Prophylaxis (PrEP) With Prevention Efforts

Trial Profile

Open Label Prospective Study of Strategies to Combine Pre-Exposure Prophylaxis (PrEP) With Prevention Efforts

Withdrawn prior to enrolment
Phase of Trial: Phase III

Latest Information Update: 19 Sep 2016

At a glance

  • Drugs Emtricitabine/tenofovir disoproxil fumarate (Primary)
  • Indications HIV infections
  • Focus Therapeutic Use
  • Acronyms SCOPE
  • Most Recent Events

    • 01 Jul 2013 Status changed from not yet recruiting to withdrawn prior to recruitment as reported by ClinicalTrials.gov.
    • 29 Apr 2013 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top